Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-10

Clinical Trial Update: Effect of Raltegravir on Endothelial Function in HIV-Infected Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of raltegravir on endothelial function in HIV-infected patients has completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Raltegravir (raltegravir)

Snippet

Sponsor: University of California, San Francisco | Conditions: HIV Infection, Inflammation | Phase 4 | Status: COMPLETED | Results posted: 2015-06-10